Martin Bergmann,Joerg Huelsken,Walter Birchmeier,Makoto Mark Taketo
申请号：
US12573281
公开号：
US08969080B2
申请日:
2009.10.05
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Disclosed is the use of inhibitors of β-catenin expression or activity or modulators downregulating β-catenin expression or activity for the treatment of cardiovascular diseases or disorders and their use in the treatment of cardiovascular diseases and disorders, such as heart failure syndrome. The use of those agents resulted in particular in cardiomyocyte differentiation of endogenous cardiac stem cells.
